Abstract
Dominant oncogenes, like myc or ras, confer a gain of func-tion to transformed cells.1,2 Gain-of-function mutations result in abnormal, positive signals for cell proliferation. In general, however, genetic alterations such as point mutations and deletions most often result in a loss of function and contribute to tumorigenesis by interference with mechanisms restraining cell proliferation. Such is the case for the Wilms tumor suppressor gene, WT1. Theoretically, mutations can occur at any site within the gene. However, it is important to consider whether the mutation results in the production of a modified protein (missense mutation) or in the production of a truncated WT1 protein (nonsense or frameshift mutation). Depending upon the biochemical function of the protein and the nature of its interaction with other proteins, missense or nonsense mutations could be expected to produce different phenotypes. And, indeed, constitutional missense mutations of the WT1 gene appear to disrupt several organ systems and result in a far more severe phenotype (Denys-Drash syndrome — DDS, see chapter 1) than constitutional deletions (WAGR syndrome) or nonsense mutations (Wilms tumor only).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Marcu KB, Bossone SA, Patel AJ: myc functiuon and regulation. Ann Rev Biochem 1992; 61: 809–860.
Lowy DR, Willumsen BM: Function and regaulation of ras. Ann Rev Biochem 1992; 62: 851–891.
Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA: The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genetics 1993; 4: 415–420.
Lewis WH, Yeger H, Bonetta L, Chan HLS, Kang J, Junien C, Cowell J, Jones C, Dafoe LA: Homozygous deletion of a DNA marker from chromosome 11p13 in sporadic Wilms tumor. Genomics 1988; 3: 25–31.
Gessler M, Poustka A, Cavenee W, Neve RL, Orkin SH, Bruns GA: Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping. Nature 1990; 343: 774–778.
Cowell JK, Wadey RB, Haber DA, Call KM, Housman DE, Pritchard J: Structural rearrangements of the WT1 gene in Wilms’ tumour cells. Oncogene 1991; 6: 595–599.
Coppes MJ, Liefers GJ, Paul P, Yeger H, Williams BRG: Homozygous somatic WTI point mutations in sporadic unilateral Wilms tumor. Proc Natl Acad Sci USA 1993; 90: 1416–1419.
Varanasi R, Bardeesy N, Ghahremani M, Petruzzi M-J, Nowak N, Adam MA, Grundy P, Shows TB, Pelletier J: Fine structure analysis of the WT1 gene in sporadic Wilms tumors. Proc Natl Acad Sci USA 1994; 91: 3554–3558.
Akasaka Y, Kikuchi H, Nagai T, Hiraoka N, Kato S, Hata J: A point mutation found in the WT1 gene in a sporadic Wilms’ tumor without genitourinary abnormalities is identical with the most frequent point mutation in Denys-Drash syndrome. FEBS 1993; 317: 39–43.
Baird PN, Santos A, Groves N, Jadresic L, Cowell JK Constitutional mutations in the WT1 gene in patients with Denys-Drash syndrome. Hum Molec Genet 1992; 1: 301–305.
Huff V, Miwa H, Haber DA, Call KM, D. H, Strong LC, G.F. S: Evidence for WT1 as a Wilms’ tumor (WT) gene: intragenic germinal deletion in bilateral WT. Am J Hum Genet 1991; 48: 997–1003.
Pelletier J, Bruening W, Li FP, Haber DA, Glaser T, Housman DE: WT1 mutations contribute to abnormal genital system development and hereditary Wilms’ tumour. Nature 1991; 353: 431–434.
Little MH, Prosser J, Condie A, Smith PJ, Van Heyningen V, Hastie ND: Zinc finger point mutations within the WT1 gene in Wilms tumor patients. Proc Natl Acad Sci USA 1992; 89: 4791–4795.
Ton CC, Huff V, Call KM, Cohn S, Strong LC, Housman DE, Saunders GF: Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. Genomics 1991; 10: 293–297.
Pavletich NP, Pabo CO: Zinc finger-DNA recognition: crystal structure of a Zif268-DNA complex at 2.1 A. Science 1991; 252: 809–817.
Haber DA, Buckler AJ, Glaser T, Call KM, Pelletier J, Sohn RL, Douglass EC, Housman DE: An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms’ tumor. Cell 1990; 61: 1257–1269.
Coppes MJ, Campbell CE, Williams BRG: The role of WTI in Wilms tumorigenesis. FASEB 1993; J 7: 886–895.
Baird PN, Groves N, Haber DA, Housman DE, Cowell JK: Identification of mutations in the WT1 gene tumours from patients with the WAGR syndrome. Oncogene 1992; 7: 2141–2149.
Fraizier GC, Wu Y-J, Hewitt SM, Maity T, Ton CCT, Huff V, Saunders GF: Transcriptional regulation of the human Wilms tumor gene (WT1). J Biol Chem 1994; 269: 8892–8900.
Coppes MJ, Bonetta L, Huang A, Hoban P, Chilton-MacNeill S, Campbell CE, Weksberg R, Yeger H, Reeve AE, Williams BRG: Loss of heterozygosity mapping in Wilms tumor indicates the involvement of three distinct regions and a limited role for non-disjunction or mitotic recombination. Genes Chrom Cancer 1992; 5: 326–334.
Herskowitz I: Functional inactivation of genes by dominant negative mutations. Nature 1987; 329: 219–222.
Finlay CA, Hinds PW, Levine AJ: The p53 proto-oncogene can act as a suppressor of transformation. Cell 1989; 57: 1083–1093.
Lavigueur A, Maltby V, Mock D, Rossant J, Pawson T, Bernstein A: High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol Cell Biol 1989; 9: 3982–3991.
Henry I, Grandjouan S, Couillin P, Barichard F, Huerre-Jeanpierre C, Glaser T, Philip T, Lenoir G, Chaussain JL, Junien C: Tumor-specific loss of 11p15.5 alleles in dell l p13 Wilms tumor and in familial adrenocortical carcinoma. Proc Natl Acad Sci USA 1989; 86: 3247–3251.
Pelletier J, Schalling M, Buckler AJ, Rogers A, Haber DA, Housman D: Expression of the Wilms’ tumor gene WT1 in the murine uro-genital system. Genes Dev 1991; 5: 1345–1356.
Coppes MJ, Ye Y, Rackley R, Zhao X-1, Liefers GJ, Casey G, Williams BRG: Analysis of WTI in granulosa cell and other sex cordstromal tumors. Cancer Res 1993; 53: 2712–2714.
Austin MB, Fechner RE, Roggli VL: Pleural malignant mesothelioma following Wilms’ tumor. Am J Clin Pathol 1986; 86: 227–230.
Rackley RR, Flenniken AM, Kuriyan NP, Kessler PM, Stoler MH, Williams BRG: Expression of the Wilms’ tumor suppressor gene WT1 during mouse embryogenesis. Cell Growth Differentiation 1993; 4: 1023–1031.
Zhou J, Rauscher FJ III, Bondy C: Wilms’ tumor (WT1) gene expression in decidual differentiation. Differentiation 1993; 54: 109–114.
Rackley R, Casey G, Zhao X-1, Miller DW, Williams BRG, Coppes MJ: Analysis of the Wilms tumor suppressor gene WTI in endometrial carcinoma. Genes Chrom Cancer 1994.
Bruening W, Gros P, Sato T, Stanirmir J, Nakamura Y, Housman D, Pelletier J: Analysis of the 11p13 Wilms’ tumor suppressor gene (WT1) in ovarian tumors. Cancer Investigat 1993; 11: 393–399.
Looijenga LHJ, Abraham M, Gillis AJM, Saunders GF, Oosterhuis JW: Testicular germ cell tumors of adults show deletions of chromosomal bands 11 p 13 and 11 p 15.5, but no abnormalities within the zinc-finger regions and exons 2 and 6 of the Wilms’ tumor I gene. Genes Chrom Cancer 1994; 9: 153–160.
Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE: Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus. Cell 1990; 60: 509–520.
Huff V, Villalba F, Strong LC, Saunders GF: Alteration of the WT1 gene in patients with Wilms’ tumor and genitourinary anomalies. Am J Hum Genet 1991; 49: 44.
Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D: Germline mutations in the Wilms’ tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991; 67: 437–447.
Bruening W, Bardeesy N, Silverman BL, Cohn RA, Aronson AJ, Housman D, Pelletier J: Germline intronic and exonic mutations in the Wilms’ tumor gene (WT1) affecting urogenital development. Nature Genetics 1992; 1: 144–148.
Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BRG: Inherited WT1 mutations in Denys-Drash syndrome. Cancer Res 1992; 52: 6125–6128.
Ogawa O, Eccles MR, Mueller RF, Holdaway MDD, Reeve AE: A novel insertional mutation at the third zinc finger coding region of the WT1 gene in Denys-Drash syndrome. Hum Molec Genet 1993; 2: 203–204.
Clarkson PA, Davies HL, Williams DM, Chaudhary R, Hughes IA, Patterson MN: Mutational screening of the Wilms’ tumor gene, WT1, in males with genital abnormalities. J Med Genet 1993; 30: 767–772.
Coppes MJ, Huff V, Pelletier J: Denys-Drash syndrome: Relating a clinical disorder to genetic alterations in the tumor suppressor gene WTI. J Ped 1993; 123: 673–678.
Nordenskjöld A, Friedman E, Anvret M: WT1 mutations in patients with Denys-Drash syndrome: A novel mutation in exon 8 and paternal allele origin. Hum Genet 1994; 93: 115–120.
Sakai A, Tadokoro K, Yanagisawa H, Nagafuchi S, Hoshikawa N, Suzuki T, Kohsaka T, Hasegawa T, Nakahori Y, Yamada M: A novel mutation of the WT1 gene (a tumor suppressor gene for Wilms’ tumor) in a patient with Denys-Drash syndrome. Hum Molec Genet 1993; 2: 1969–1970.
Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, van Heyningen V: Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Molec Genet 1993; 2: 259–264.
Pritchard-Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier J, Housman D, Van Heyningen V, Hastie N: The candidate Wilms’ tumour gene is involved in genitourinary development. Nature 1990; 346: 194–197.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Coppes, M.J., Campbell, C., Williams, B.R.G. (1995). Naturally Occurring Mutations in the WTI Gene. In: Wilms Tumor: Clinical and Molecular Characterization. Molecular Biology Intelligence Unit. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-22621-6_7
Download citation
DOI: https://doi.org/10.1007/978-3-662-22621-6_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-22623-0
Online ISBN: 978-3-662-22621-6
eBook Packages: Springer Book Archive